FDA Drug Application (062691) for TIMENTIN by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number062691
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTIMENTIN
Active IngredientCLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

Active IngredientCount
List of drugs with Active Ingredient CLAVULANATE POTASSIUM11
List of drugs with Active Ingredient TICARCILLIN DISODIUM3


Back to FDA Applications sponsored by GLAXOSMITHKLINE